色播婷婷电影综合社区,AV女优不卡亚洲在线,99999AV,日韩人妻中文字幕视频,国产拍自偷,91人人妻,超碰在线81,免费福利视频一区,九草青草原在线看

Tianchi Pharmaceutical Co., Ltd. was founded in 2011 and is a national high-tech enterprise invested by natural persons, venture capital funds, and state-owned companies. It holds 10 national invention patents with independent intellectual property rights and 8 scientific and technological achievements. The company has established the Henan Provincial Engineering Technology Research Center for Chiral Chemical New Materials and is a key enterprise in Henan Province designated for future listing. The company operates three modern production bases across two locations: Puyang Tianjian Biotechnology, Tianchi (Puyang) New Materials, and Tianchi (Anyang) New Materials.

As the initial base of Tianchi Pharmaceutical, Puyang Tianjian Biotechnology Co., Ltd. has defined its development direction as an innovative and green fine chemical enterprise. It continuously advances in the fields of advanced pharmaceutical intermediates, chiral resolving agents, electronic and polymer new materials, and maintains close cooperation with several multinational chemical giants, creating sustainable development and value for relevant stakeholders in the industry. The enterprise generates an annual profit and tax revenue of over 20 million yuan. Pursuing excellence, quality, core competitiveness, and social responsibility, the company adheres to the corporate mission of "benefiting humanity through technology and innovation" and looks forward to sincere cooperation with domestic and international clients to achieve mutual success.

Today, Tianchi Pharmaceutical has established close partnerships with outstanding universities, research institutions, and industry leaders both domestically and internationally. It is diligently working towards the development of various細(xì)分 products in the three major categories of pharmaceuticals, pesticides, and new materials, striving to become one of the top 100 chemical enterprises in China.

In the future, Tianchi Pharmaceutical will continue to adhere to a strategy of modernization, intelligence, and serialization. Guided by market demand and driven by technological innovation, the company will persistently leverage its advantages to conduct in-depth research and development in前瞻性 fields and application areas. It will continuously explore the future of chemistry and new materials, strengthen its advantages, and strive to become a leader in the industry.